Abstract
In recent years, a variety of studies have been conducted towards the goal of achieving regeneration of the central nervous system using neural stem cells. However, various complex factors are involved in the regulation of neural stem cell differentiation, and many unresolved questions remain. It has been reported that after spinal cord injury, the intrinsic neural stem cells do not differentiate into neurons but into astrocytes, resulting in the formation of glial scars. Based on reports that the expression of IL-6 and the IL-6 receptor is sharply increased in the acute stages after spinal cord injury and that IL-6 may serve as a factor strongly inducing the differentiation of neural stem cells into astrocytes, we examined the effects of an antibody to the IL-6 receptor in cases of spinal cord injury and found that the antibody indeed suppressed secondary injury (caused by inflammatory reactions) and glial scar formation, facilitating functional recovery. In this paper, we present the data from this investigation and discuss the relationship between IL-6 signals and spinal cord injury.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hugenholtz H (2003) Methylprednisolone for acute spinal cord injury: not a standard of care. Can Med Assoc J 168:1145–1146
Reynolds BA, Tetzlaff W, Weiss S (1992) A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci 12:4565–4574
Okano H (2002) The stem cell biology of the central nervous system. J Neurosci Res 69:698–707
Johansson CB, Momma S, Clarke DL et al (1999) Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96:25–34
Bradbury EJ, Moon LD, Popat RJ et al (2002) Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416:636–640
Nakamura M, Houghtling RA, MacArthur L, Bayer BM, Bregman BS (2003) Differences in cytokine gene expression profile between acute and secondary injury in adult rat spinal cord. Exp Neurol 184:313–325
Taga T, Kishimoto T (1997) Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15:797–819
Okada S, Nakamura M, Mikami Y et al (2004) Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J Neurosci Res 76:265–276
Bonni A, Sun Y, Nadal-Vicens M et al (1997) Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278:477–483
Klein MA, Moller JC, Jones LL et al (1997) Impaired neuroglial activation in interleukin-6 deficient mice. Glia 19:227–233
Brunello AG, Weissenberger J, Kappeler A et al (2000) Astrocytic alterations in interleukin-6/Soluble interleukin-6 receptor alpha double-transgenic mice. Am J Pathol 157:1485–1493
Lacroix S, Chang L, Rose-John S, Tuszynski MH (2002) Delivery of hyper-interleukin-6 to the injured spinal cord increases neutrophil and macrophage infiltration and inhibits axonal growth. J Comp Neurol 454:213–228
Ma M, Basso DM, Walters P, Stokes BT, Jakeman LB (2001) Behavioral and histological outcomes following graded spinal cord contusion injury in the C57Bl/6 mouse. Exp Neurol 169:239–254
Dumont AS, Dumont RJ, Oskouian RJ (2002) Will improved understanding of the pathophysiological mechanisms involved in acute spinal cord injury improve the potential for therapeutic intervention? Curr Opin Neurol 15:713–720
Popovich PG, Jones TB (2003) Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol Sci 24:13–17
Mukaino M, Nakamura M, Yamada O et al (2010) Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation. Exp Neurol 224: 403–414
Guerrero AR, Uchida K, Nakajima H et al (2012) Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J Neuroinflammation 9:40
Choy EH, Isenberg DA, Garrood T et al (2002) Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose- escalation trial. Arthritis Rheum 46:3143–3150
Marz P, Cheng JG, Gadient RA et al (1998) Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci USA 95:3251–3256
Loddick SA, Turnbull AV, Rothwell NJ (1998) Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 18:176–179
Okano H, Ogawa Y, Nakamura M et al (2003) Transplantation of neural stem cells into the spinal cord after injury. Semin Cell Dev Biol 14:191–198
Okano H, Nakamura M, Yoshida K et al (2013) Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res 112(3):523–533
Nakamura M, Okano H (2013) Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells. Cell Res 23(1):70–80
Conflict of Interest  The author declares that he has no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this chapter
Cite this chapter
Nakamura, M. (2014). Microenvironment Within the Injured Spinal Cord Focusing on IL-6. In: Uchida, K., Nakamura, M., Ozawa, H., Katoh, S., Toyama, Y. (eds) Neuroprotection and Regeneration of the Spinal Cord. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54502-6_2
Download citation
DOI: https://doi.org/10.1007/978-4-431-54502-6_2
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54501-9
Online ISBN: 978-4-431-54502-6
eBook Packages: MedicineMedicine (R0)